Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on September 29, 2026

Sep. 29, 2026

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Indeterminate GlobeNewswire

Sep. 29, 2026

DiFusion to Define Therapeutic Biomaterials Category at NASS 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference

Indeterminate GlobeNewswire

Sep. 29, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire

Sep. 29, 2026

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Indeterminate GlobeNewswire

Sep. 29, 2026

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Indeterminate GlobeNewswire

Sep. 29, 2026

Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong

Indeterminate GlobeNewswire

Sep. 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Indeterminate GlobeNewswire

Sep. 29, 2026

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

Indeterminate GlobeNewswire

Sep. 29, 2026

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Sep. 29, 2026

Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO

Indeterminate GlobeNewswire

Sep. 29, 2026

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

Indeterminate GlobeNewswire

Sep. 29, 2026

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Indeterminate GlobeNewswire

Sep. 29, 2026

Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

Indeterminate GlobeNewswire

Sep. 29, 2026

Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 29, 2026

IMUNON Converts $1.2 Million of Debt-to-Equity

Indeterminate GlobeNewswire

Sep. 29, 2026

Knight Therapeutics Enters into Exclusive Distribution Agreement with Kyowa Kirin International for Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Thérapeutique Knight conclut une entente de distribution exclusive avec Kyowa Kirin International pour Poteligeo® (Mogamulizumab)

Indeterminate GlobeNewswire

Sep. 29, 2026

Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB

Indeterminate GlobeNewswire